• Patient Portal
  • Telehealth portal 
  • Wellness portal 
  • Blog
  • Home
  • Referrals
  • Contact
  • Dream Project
  • Infectious Diseases

    Excellence in patient care, education, research, public health, and prevention relating to infectious diseases.

  • Wellness

    Regional Wellness Center- For a healthier you

  • Wound Care

    Advanced healing with basic and latest techniques

  • Clinical Research

    Giving patients access to Experimental Treatments before they are widely available

  • Infusion Center

    Delivery of extraordinary patient care in outpatient setting

  • Hyperbaric Oxygen Therapy

    Promoting healing using oxygen

  • Infection Control

    Prevent and control healthcare-associated infections

  • Regenerative Medicine

    Process of regenerating human cells, tissues or organs to restore or establish normal function

  • Telemedicine

    Your doctor anywhere - Leading the way in excellent patient care

Our Services

  • Infectious Diseases
  • Infection Control
  • Clinical Research
  • Wound Care
  • For Pharmaceutical Companies
  • Hyperbaric Oxygen Therapy
  • Interesting Links
  • Office Policy
  • Terms of Use and Disclaimers
  • Ambulatory Infusion Suite
  • For HealthCare Providers
  • Medical Services

    Medical Services

    Infectious Disease Consultations (Diagnosis and management of infections)

    Read More
  • Affiliations

    Affiliations

    RIDIC is closely affiliated with the following Hospitals..

    Read More
  • Patient Education

    Patient Education

    By health professionals and others provide impart information to patients.

    Read More
  • Community Involvement

    Community Involvement

    RIDIC Involved in community health fair and some other..

    Read More

Mission Statement

RID-IC provides infectious diseases services including: direct patient care, diagnosis and treatment of infectious diseases, infusion services, and wound care. To that end, a patient-centered office that provides cost effective care has been developed.

Read More

Patient Comments

I am recovering from a illness that could have been very serious. Thanks to my wonderful doctors, Vivian Hobayan, Ravi Kamepalli, and William Sanko, for their prompt diagnosis and treatment.

Read More

Practical Approach to Problem Wounds

Practical Approach to Problem Wounds

To view the full length Video

Please fill the form

 

*Once you submit you will get a email with a password for the video.

Company Research Articles and Presentations

  • Click Here Poster for Fecal Bacteriotherapy Treatment for Clostridium Difficile Infection- "Presented at ID WEEK 2013"
  • Click Here PRP with small Intestine Submucosa Layer(SIS) poster - "Presented at SAWC Spring 2013"
  • Click Here PRP poster for complex surgical wounds - "Presented at SAWC FALL 2011"

 

What is Microbiome?

 

Infectious Diseases Feed

  • Identifying more than 1 in 5 CRE carriers yields substantial reductions in transmission
    Researchers found that identifying more than one in five carriers of carbapenem-resistant Enterobacteriaceae, or CRE, can “substantially dampen...
  • New York man first known in US to be bitten by Asian longhorned tick
    A man from Yonkers, New York, was recognized as the first human in the United States to be bitten by the Haemaphysalis longicornis tick, also known...
  • WHO: Ebola outbreak not an international health emergency despite deaths in Uganda
    Today, an emergency committee convened by WHO Director-General Tedros Adhanom Ghebreyesus, PhD, MSc, for the third time, determined that the current...
  • HCV treatment with Epclusa safe in patients undergoing dialysis for ESRD
    Although not currently licensed for patients undergoing dialysis for severe renal impairment, researchers found that treatment with Epclusa for...
  • Should the US government leverage patents held by the CDC to push down the price of Truvada?
    I am impressed by the fact that Gilead Sciences did two things: They accelerated the patent expiration date for Truvada (emtricitabine/tenofovir...
  • Female external catheters cut CAUTI rate by more than 50%
    PHILADELPHIA — A new type of female indwelling catheter technology reduced inpatient catheter-associated UTIs, or CAUTIs, by 51.7%, according to...
  • FDA issues safety alert on fecal transplants after patient dies
    Two adults with weakened immune systems who received investigational fecal microbiota transplantations developed invasive infections caused by...
  • Young MSM may not completely recover from PrEP-related bone density loss
    Adolescents who take pre-exposure prophylaxis, or PrEP, for HIV prevention may experience a loss of bone mineral density during treatment. Most...
  • Metagenomic sequencing improves diagnosis of neurologic infections
    Metagenomic next-generation sequencing, or NGS, of cerebrospinal fluid can improve the diagnosis of neurologic infections in patients with...
  • VIDEO: Supporting the role of the infection preventionist
    PHILADELPHIA — In this video from the annual conference of the Association for Professionals in Infection Control and Epidemiology, Karen Jones,...
  • ECHO trial: HIV risk does not differ by contraceptive method
    In reassuring findings for women seeking birth control options, researchers said they found no substantial difference in risk for HIV infection...
  • Pseudo-outbreak of B. cepacia linked to refilled ultrasound gel bottles
    PHILADELPHIA — A pseudo-outbreak of Burkholderia cepacia in a hospital ED was linked to ultrasound gel bottles that had been refilled by members of...
  • CDC: Bats are leading cause of rabies infection in US
    Bats are responsible for most rabies cases in the United States, accounting for roughly 70% of locally acquired infections over the past 6o years,...
  • Public health leaders commit to promoting global vaccine acceptance
    The Salzburg Global Fellows, an international group of public health leaders, has issued a statement confirming its commitment to worldwide vaccine...
  • Investing in infection prevention improves care, saves money
    PHILADELPHIA — Implementing chlorhexidine gluconate, or CHG, bathing for every patient led to significant reductions in health care-associated...
  • European guidelines recommend letermovir as CMV prophylaxis in HSCT recipients
    Updated clinical practice guidelines prepared by the European Conference on Infections in Leukemia recommend the use of letermovir for the...
  • Q&A: China’s control strategy for H7N9 flu virus
    In 2013, China experienced the first outbreak of avian influenza A(H7N9).
    Since then, the country has implemented many interventions to control...
  • Just one antibiotic course could contribute to resistance
    One course of antibiotics could expand the gut resistome in children, according to the results of a randomized clinical trial published in Clinical...
  • Officials confirm Ebola case in Uganda
    A 5-year-old boy infected with Ebola virus crossed the border into Uganda from the Democratic Republic of the Congo, or DRC, health officials said...
  • L. infantum prevalent among Barcelona sewer rats
    Around one-third of Norway rats, or Rattus norvegicus, captured in the sewers of Barcelona tested positive for Leishmania infantum, indicating a...

Quick Menu

  • Home
  • About Us
  • Medical Services
  • Affiliations
  • Patient Education
  • Community Involvement
  • Mission Statement
  • Patient Comments

Services

  • Infectious Diseases
  • Infection Control
  • Clinical Research
  • Wound Care
  • For Pharmaceutical Companies
  • Hyperbaric Oxygen Therapy
  • Interesting Links
  • Office Policy
  • Terms of Use and Disclaimers
  • Ambulatory Infusion Suite
  • For HealthCare Providers

Address

Regional Infectious Diseases and Infusion center, Inc.

830 West High street,
Suite 255, Lima,
OH 45801 USA

Telephone: 419-228-1535
Fax: 419-227-1410
Research Department Fax: 419-228-1532
Mobile: 1-877-537-4342

© 2019 NO BAD BUGS